As per the agreement between Pakistan Muslim League-Nawaz (PML-N) and Jamaat-e-Islami (JI), the term of JI's Vice President Khalid Mirza has ended. Ignoring the expected candidate and former Vice ...

Plea deals for accused 9/11 mastermind Khalid Sheikh Muhammad and two others are back on the table after a military judge reversed an order by the U.S. secretary of defense, according to multiple ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

WASHINGTON — A military judge has ruled that plea agreements struck by alleged Sept. 11 mastermind Khalid Sheikh Mohammed and two co-defendants are valid, voiding an order by Defense Secretary ...

WASHINGTON — A military judge has ruled that plea agreements struck by alleged Sept. 11 mastermind Khalid Sheikh Mohammed and two co-defendants are valid, voiding an order by Defense Secretary ...

11 mastermind Khalid Sheikh Mohammed and two co-defendants are valid, voiding an order by Defense Secretary Lloyd Austin to throw out the deals, a government official said. The official spoke on ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be in the works from Korea’s Alteogen following a licensing deal worth ...

Asma Khalid is a White House correspondent for NPR. She also co-hosts The NPR Politics Podcast. Khalid is a bit of a campaign-trail addict, having reported on the 2014, 2016, 2018 and 2020 elections.

As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...

An oil well seen in this image. — AFP/file ISLAMABAD: The oil industry has voiced serious concerns over the government’s deviation from the... A representational image of an oil refinery ...